ArticleScientific reports2022
Application of 233 nm far-UVC LEDs for eradication of MRSA and MSSA and risk assessment on skin models.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 62 citations in OpenAlex.
- Use of Ultraviolet C-Radiation Therapy in Trauma and Orthopaedics: A Current State of Evidence.Cureus · 2026Review
- Corneal safety assessment of germicidal far UV-C radiation.Scientific reports · 2025Article
- Assessment of the anti-biofilm effect of UV-C irradiation (254 nm) against healthcare associated infections related microorganisms.Frontiers in microbiology · 2025Article
- Article
- Effectiveness of UmoniumBMC infectious diseases · 2024Article
- Significance of melanin distribution in the epidermis for the protective effect against UV light.Scientific reports · 2024Article
- Enhanced vegetable production in hydroponic systems using decontamination of closed circulating fluid.Scientific reports · 2024Article
- Sensitivity Analysis ofPathogens & immunity · 2024Article
- Irradiation of human oral mucosa by 233 nm far UV-C LEDs for the safe inactivation of nosocomial pathogens.Scientific reports · 2023Article
- Semantic modeling of cell damage prediction: a machine learning approach at human-level performance in dermatology.Scientific reports · 2023Article
- Phenotypic Variation in ClinicalMicroorganisms · 2023Article
- Far-UVC Radiation for Disinfecting Hands or Gloves?Pathogens (Basel, Switzerland) · 2023Article
- UV radiation sensitivity of bacteriophage PhiX174 - A potential surrogate for SARS-CoV-2 in terms of radiation inactivation.AIMS microbiology · 2023Article
- Sensitivity of influenza virus to ultraviolet irradiation.GMS hygiene and infection control · 2022Review
- Wavelength, dose, skin type and skin model related radical formation in skin.Biophysical reviews · 2021Review
- Virus inactivation and skin safety studies using far-UVC LEDs.Photochemistry and photobiologyArticle
- Germicidal potential and skin compatibility of an innovative UVC phototherapy device emitting at 234 nm.Photochemistry and photobiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A newly developed UVC LED source with an emission wavelength of 233 nm was proved on bactericidal efficacy and skin tolerability. The bactericidal efficacy was qualitatively analysed using blood agar test. Subsequently, quantitative analyses were performed on germ carrier tests using the MRSA strain DSM11822, the MSSA strain DSM799, S. epidermidis DSM1798 with various soil loads. Additionally, the compatibility of the germicidal radiation doses on excised human skin and reconstructed human epidermis was proved. Cell viability, DNA damage and production of radicals were assessed in comparison to typical UVC radiation from discharge lamps (222 nm, 254 nm) and UVB (280-380 nm) radiation for clinical assessment. At a dose of 40 mJ/cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.